6 курс / Гастроэнтерология / Багненко_С_С_Комплексное_магнитно_резонансное_исследование_в_выявлении
.pdf271
damage after liver resection-preliminary data / S. Bickelhaupt, P. Studer, C. Kim-Fuchs
[et al.] // Clinical radiology. – 2013. – Vol. 68, N 11. – P. 1121–1127.
86. Bitar, R. MR pulse sequences: what every radiologist wants to know but is
afraid to ask / R. Bitar, G. Leung, R. Perng [et al.] // RadioGraphics. – 2006. – Vol. 26.
– P. 513–537.
87. Blumgart, L. H. Hepatobiliary cancer / L .H. Blumgart, Y. Fong,
W.R. Jarnagin. – Hamilton-London: B. C. Decker, 2001. – 304 p.
88.Bogner, W. In vivo 31P spectroscopy by fully adiabatic extended image
selected in vivo spectroscopy: a comparison between 3 T and 7 T / W. Bogner, M. Chmelik, O. C. Andronesi [et al.] // Magnetic resonance in medicine. – 2011. – Vol. 66, N 4. – P. 923–930.
89.Boll, D. T. Pilot study assessing differentiation of steatosis hepatic, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique / D. T. Boll, D. Marin, G. M. Redmon [et al.] // Amer. J. of roentgenology: AJR. – 2010. – Vol. 194, N 4. – P. 964–971.
90.Boraschi, P. Biliary-enteric anastomoses: spectrum of findings on Gd-EOB-DTPA-enhanced MR cholangiography / P. Boraschi, F. Donati // Abdominal imaging. – 2013. – Vol. 38, N 6. – P. 1351–1359.
91.Braun, B. Focal liver processes: «better is the enemy of good»: CEUS in the fast lane // Ultraschall in der Medizin. – 2009. – Vol. 30, N 4. – P. 329–332.
92.Bremer, C. Accuracy of nonenhanced MRI to monitor histological lesion size during laser-induced interstitial thermotherapy / C. Bremer, G. Kreft, T. Filler [et al.] // Europ. radiology. – 2002. – Vol. 12. – P. 237–244.
93.Burim, C. V. Differentiation between simple cyst and hepatic hemangioma utilizing T2-weighted magnetic resonance imaging with gradient-echo (b-FFE) technique / C. V. Burim, L. P. Neto, F. G. Torlai [et al.] // Radiologia Brasileria. – 2008.
–Vol. 41, N 6. – P. 355–360.
94.Campos, J. T. Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas / J. T. Campos, C. B. Sirlin, J. Y. Choi // Insights imaging. – 2012. – Vol. 3, N 5. –
P. 451–474.
272
95.Cao, Y. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging / Y. Cao, H. Wang, T. D. Johnson [et al.] // Intern. J. of radiation oncology, biology, physics. – 2013. – Vol. 85, N 1. – P. 258–263.
96.Cardanel, J. F. Practices of liver biopsy in France: results of prospective nationwide survey / J. F. Cardanel, P. Rufat, F. Degos // Hepatology. – 2000. – Vol. 32, N 3. – P. 477–481.
97.Chan, V. O. Diagnostic performance of MDCT, PET/CT and gadoxetic
acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being
considered for hepatic resection: initial experience in a single centre / V. O. Chan,
J. P. Das, J. F. Gerstenmaier [et al.] // Irish J. of med. sciences. – 2012. – Vol. 181, N 4.
– P. 499–509.
98. Chavhan, G. B. Steady-state MR imaging sequences: physics, classification, and clinical applications / G. B. Chavhan, P. S. Babyn, B. G. Jankharia [et al.] // RadioGraphics. – 2008. – Vol. 28. – P. 1147–1160.
99.Chen, J. H. Fat-free MRI based on magnetization exchange / J. H. Chen, H. C. Le, J. A. Koutcher [et al.] // Magnetic resonance in medicine. – 2010. – Vol. 63, N 3. – P. 713–718.
100.Chernyak, V. Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors / V. Chernyak, J. Kim, A. M. Rozenblit [et al.] // J. of magnetic resonance imaging. – 2011. – Vol. 34, N 2. – P. 301–309.
101.Choi, J. S. Comparison of breathhold, navigator-triggered, and free-
breathing diffusion-weighted MRI for focal hepatic lesions / J. S. Choi, M. J. Kim, Y. E. Chung [et al.] // J. of magnetic resonance imaging. – 2013. – Vol. 38, N 1. –
P.109–118.
102.Choi, J. W. Hepatocellular carcinoma: imaging patterns on gadoxetic acidenhanced MR Images and their value as an imaging biomarker / J. W. Choi, J. M. Lee, S. J. Kim [et al.] // Radiology. – 2013. – Vol. 267, N 3. – P. 776–786.
103. Chong, Y. S. |
Differentiating |
mass-forming |
intrahepatic |
cholangiocarcinoma from atypical hepatocellular |
carcinoma using |
gadoxetic acid- |
|
273
enhanced MRI / Y. S. Chong, Y. K. Kim, M. W. Lee [et al.] // Clinical radiology. – 2012. – Vol. 67, N 8. – P. 766–773.
104. Chou, C. T. Characterization of cirrhotic nodules with gadoxetic acidenhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging / C. T. Chou, Y. L. Chen, W. W. Su [et al.] // J. of magnetic resonace imaging. – 2010. – Vol. 32, N 4. – P. 895–902.
105.Chrysochou, C. Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience / C. Chrysochou, D. L. Buckley, P. Dark [et al.] // J. of magnetic resonance imaging. – 2009. – Vol. 29, N 4. – P. 887–894.
106.Chu, W. C. Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive assessment of graft status with correlation with liver function tests and liver biopsy / W. C. Chu, W. W. Lam, K. H. Lee [et al.] // Amer. J. of roentgenology. – 2005. – Vol. 184, N 5. – P. 1624–1629.
107.Chun, H. L. Focal nodular hyperplasia: what are the indications for resection / H. L. Chun, J. L. McCall, J. B. Koea // Offic. J. of Intern. Hepato Pancreato Biliary Assoc. (HPB). – 2005. – Vol. 7, N 4. – P. 298–302.
108.Chung, H. W. T2-weighted fast MR imaging with true FISP versus HASTE. Comparative efficacy in the evaluation of normal fetal brain maturation /
H. W. Chung, C. Y. Chen, R. A. Zimmerman [et al.] / Neuroradiology. – 2000. – Vol. 175, N 5. – P. 1375–1380.
109. Cieszanowski, A. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times / A. Cieszanowski, A. Anysz-Grodzicka, W. Szeszkowski [et al.] // Europ. radiology. – 2012. – Vol. 22, N 11. – P. 2514–2524.
110.Cieszanowski, A. Detection of active bile leak with Gd-EOB-DTPA enhanced MR cholangiography: comparison of 20–25 min delayed and 60–180 min delayed images / A. Cieszanowski, A. Stadnik, A. Lezak [et al.] // Europ. J. of radiology. – 2013. – Vol. 82, N 12. – P. 2176–2182.
111.Coenegrachts, K. Magnetic resonance imaging of the liver: new imaging
274
strategies for evaluating focal liver lesions // World J. of radiology. – 2009. – Vol. 1,
N 1. – P. 72–85.
112. Coenegrachts, K. Prediction and monitoring of treatment effect using
T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver
metastases: potential of whole tumour ROI and selective ROI analysis /
K. Coenegrachts, A. Bols, M. Haspeslagh [et al.] // Europ. J. of radiology. – 2012. – Vol. 81, N 12. – P. 3870–3876.
113. Corbin, I. R. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis / I. R. Corbin, L. N. Ryner, H. Singh [et al.] // Amer. J. of physiology – gastrointestinal a. liver physiology. – 2004.
–Vol. 287, N 2. – P. 379–384.
114.Corbin, I. R. Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure / I. R. Corbin, R. Buist, J. Peeling [et al.] // J. of investigative medicine. – 2003. – Vol. 51, N 1. – P. 42–49.
115.Dagnelie, P. C. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer / P. C. Dagnelie, S. LeijHalfwerk // World J. of gastroenterology. – 2010. – Vol. 16, N 13. – P. 1577–1586.
116.Dahlström, N. Quantitative evaluation of contrast agent dynamics in liver MRI / N. Dahlström. – Linköping, 2010. – 93 p. – (Linköping University Medical
Dissertations ; N 1196).
117. Décarie, P. O. Fatty liver deposition and sparing: a pictorial review /
P. O. Décarie, L. Lepanto, J. S. Billiard [et al.] // Insights imaging. – 2011. – Vol. 2,
N 5. – P. 533–538.
118. Dezortova, M. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy / M. Dezortova, P. Taimr, A. Skoch [et al.] // World J. of gastroenterology. – 2005. – Vol. 28, N 44. – P. 6926–6931.
119. Diffusion-Weighted MR Imaging: applications in the body / ed. by
D.M. Koh, H. C. Thoeny. – Berlin: Springer, 2010. – 299 p.
120.Do, R. K. G. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions / R. K. G. Do, H. Rusinek, B. Taouli // Magnetic resonance
275
imaging clinics of North America. – 2009. – Vol. 17, N 2. – P. 339–349.
121. Dobritz, M. VIBE with parallel acquisition technique – a novel approach to dynamic contrast-enhanced MR imaging of theliver / M. Dobritz, T. Radkow, M. Nittka [et al.] // Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin:
RöFo. – 2002. – Bd. 174, N 6. – S. 738–741.
122.Downey, R. T. Advances in biliary imaging / R. T. Downey, S. A. Wells, P. S. Liu // Europ. J. of clinical a. med. oncology. – 2010. – Vol. 2, N 4. – P. 1–8.
123. Doyle, F. H. NMRI of the liver: initial experience / F. H. Doyle, J. M. Pennock, L. M. Banks [et al.] // Amer. J. of roentgenology. – 1982. – Vol. 138,
N2. – P. 193–200.
124.Dym, R. J. MR imaging of renal collecting system with gadoxetate disodium: feasibility for MR urography / R. J. Dym, V. Chernyak, A. M. Rozenblit // J. of magnetic resonance maging. – 2013. – Vol. 38, N 4. – P. 816–823.
125.Earls, J. P. Liver MRI [Electronic research] // Advanced MRI 2002 – from head to toe, Austria, Graz. – URL: http://mri.cpson.com/pdf/Liver_MRI.pdf
126.Faisal, K. F. Hypervascular liver lesions on MRI / K. F. Faisal, A. N. Khan, R. L. Eisenberg // Amer. J. of roentgenology: AJR. – 2011. – Vol. 197. – P. W204–
W220.
127.Federle, M. P. Diagnostic imaging: abdomen / M. P. Federle, R. B. Jeffrey, P. J. Woodward [et al.]. – 2nd ed. – Salt Lake City (Utah): Amirsys, 2010. – 1288 p.
128. Focal liver lesions: (detection, characterization, ablation) / ed. by R. Lencioni, D. Cioni, C. Bartolozzi. – Berlin; Heidelberg; New York: Springer, 2005. – 404 p.
129. Germain, D. MR monitoring of tumour thermal therapy / D. Germain,
P.Chevallier, A. Laurent [et al.] // MAGMA. – 2001. – Vol. 13. – P. 47–59.
130.Gharbi, H. A. Ultrasound examination of the hydatic liver / H. A. Gharbi, W. Hassine, M. W. Brauner [et al.] // Radiology. – 1981. – Vol. 139. – P. 459–463.
131.Giesel, F. L. Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI / F. L. Giesel, C. Kratochwil, A. Mehndiratta [et al.] //
276
Europ. J. of radiology. – 2012. – Vol. 81, N 10. – P. 2820–2825.
132.Girometti, R. Accuracy of visual analysis vs. apparent diffusion coefficient quantification in differentiating solid benign andmalignant focal liver lesions with diffusion-weighted imaging / R. Girometti, M. Del Pin, S. Pullini [et al.] // Radiological medicine. – 2013. – Vol. 118, N 3. – P. 343–355.
133.Glockner, J. F. Hepatobiliary MRI: current concepts and controversies // J. of magnetic resonance imaging. – 2007. – Vol. 25, N 4. – P. 681–695.
134.Godfrey, E. M. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis / E. M. Godfrey, A. J. Patterson, A. N. Priest [et al.] // Europ. radiology. – 2012. – Vol. 22, N 12. – P. 2790–2797.
135.Golfieri, R. Contribution of the hepatobiliary phase of Gd-EOB-DTPA- enhanced MRI to dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis / R. Golfieri, M. Renzulli, V. Lucidi [et al.] // Europ. radiology. – 2011. –
Vol. 21, N 6. – P. 1233–1242.
136. Golfieri, R. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration / R. Golfieri, L. Grazioli, E. Orlando [et al.] // J. of magnetic resonance imaging. – 2012. – Vol. 36, N 3. –
P.648–657.
137.Gong, N. J. Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison
with positron emission tomography/computed tomography / N. J. Gong, C. S. Wong,
Y.C. Chu [et al.] // NMR in biomedicine. – 2013. – Vol. 26. N 2. – P. 185–192.
138.Goodwin, M. D. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents / M. D. Goodwin, J. E. Dobson, C. B. Sirlin [et al.] // RadioGraphics. – 2011. – Vol. 31, N 6. – P. 1547–1568.
139.Gourtsoyianni, S. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation
between most commonly encountered benign and malignant focal liver lesions / S. Gourtsoyianni, N. Papanikolaou, S. Yarmenitis [et al.] // Europ. radiology. – 2008. –
277
Vol. 18, N 3. – P. 486–492.
140.Granito, A. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of smallhepatocellular carcinoma: a prospective study / A. Granito, M. Galassi, F. Piscaglia [et al.] // Alimentary pharmacology a. therapeutics. – 2013. – Vol. 37, N 3. – P. 355–363.
141.Gunsar, F. Nutritional status and prognosis in cirrhotic patients / F. Gunsar, M. L. Raimondo, S. Jones [et al.] // Alimentary pharmacology a. therapeutics. – 2006. –
Vol. 24, N 4. – P. 563–572.
142. Hahn, E. L. Spin-echoes // Physical rev. – 1950. – Vol. 80, N 4. – P. 580–
594.
143. Haimerl, M. Added value of Gd-EOB-DTPA – enhanced hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions [Electronic research] / M. Haimerl, M. Wächtler, I. Platzek [et al.] // BMC med. imaging. – 2013. – Vol. 13. – URL: http://www.biomedcentral.com/1471-2342/13/41/abstract
144.Heijmen, L. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation / L. Heijmen, E. E. Ter Voert, I. D. Nagtegaal [et al.] // Europ. radiology. – 2013. – Vol. 23, N 3. – P. 748–756.
145.Henninger, B. Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload / B. Henninger, C. Kremser, S. Rauch [et al.] // Europ. radiology. – 2012. – Vol. 22, N 11. – P. 2478–2486.
146. Herborn, C. U. MRI of the liver: can True FISP replace HASTE? /
C. U. Herborn, F. Vogt, T. C. Lauenstein [et al.] // J. of magnetic resonance imaging. – 2003. – Vol. 17, N 2. – P. 190–196.
147. Herédia, V. Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content / V. Herédia, M. Ramalho, R. O. P. de Campos [et al.] // J. of magnetic resonance imaging. – 2012. – Vol. 35, N 5.
–P. 1112–1118.
148.Heye, T. Liver imaging today [Electronic research] / T. Heye, M. R. Bashir // MAGNETOM Flash. – 2013. – N 2. – URL: www.siemens.com/magnetom-world
149.Holzapfel, K. Characterization of small (≤10 mm) focal liver lesions: value
278
of respiratory-triggered echo-planar diffusion-weighted MR imaging / K. Holzapfel, M. Bruegel, M. Eiber [et al.] // Europ. J. of radiology. – 2010. – Vol. 76, N 1. – P. 89– 95.
150.Holzapfel, K. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of livermetastases in patients operated for pancreatic cancer / K. Holzapfel, C. Reiser-Erkan, A. A. Fingerle [et al.] // Abdominal imaging. – 2011. – Vol. 36, N 2. – P. 179–184.
151.Imam, K. MR imaging in the evaluation of hepatic metastases / K. Imam,
D. A. Bluemke // Magnetic resonance imaging clinics of North America. – 2000. –
Vol. 8, N 4. – P. 741–756.
152.Inoue, T. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors [Electronic research] / T. Inoue, T. Hyodo, T. Murakami [et al.] // Digestive diseases a. sciences. – 2013. – Vol. 31, N 5/6. – URL: http://www.ncbi.nlm.nih.gov/m/pubmed/24281023
153.Irie, H. Pitfalls in MR Cholangiopancreatographic interpretetion / H. Irie, H. Honda, T. Kuroiwa [et al.] // RadioGraphics. – 2001. – Vol. 21, N 3. – P. 23–37.
154.Jiang, T. Diagnosis of rejection after liver transplantation: use of
phosphorus-31 magnetic resonance spectroscopy ((31) P-MRS) / T. Jiang, S. Liu,
X.Xiao [et al.] // Abdominal imaging. – 2012. – Vol. 37, N 5. – P. 788–794.
155.Kai, K. Usual and unusual gross appearance of hepatocellular carcinomas / K. Kai, A. Miyoshi, K. Kitahara [et al.] // Hepatocellular carcinoma – clinical research / ed. by J. W. Y. Lau. – Rijeka, 2012. – Ch. 8. – P. 155–180.
156.Kamel, I. R. MR imaging of liver tumors / I. R. Kamel, D. A. Bluemke // Radiologic clinics of North America. – 2003. – Vol. 41. – P. 51–65.
157.Khan, S. A. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications /
S. A. Khan, I. J. Cox, G. Hamilton [et al.] // Liver Intern. – 2005. – Vol. 25, N 2. –
P. 273–281.
279
158. Kilickesmez, O. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses / O. Kilickesmez, S. Bayramoglu, E. Inci [et al.] // J. of med. imaging a. radiation oncology. – 2009. – Vol. 53, N 1. – P. 50–55.
159.Kim, B. S. Comparison of three free-breathing T2-weighted MRI sequences in the evaluation of focal liver lesions // B. S. Kim, J. H. Kim, G. M. Choi1 [et al.] // Hepatobiliary imaging. – 2008. – Vol. 190, N 1. – P. 19–27.
160.Kim, D. J. Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with «washout» appearance on dynamic MRI /
D. J. Kim, J. S. Yu, J. H. Kim [et al.] // Brit. J. of radiology. – 2012. – Vol. 85, N 1018.
–P. 879–886.
161.Kim, M. J. Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging / M. J. Kim, M. Lee, J. Y. Choi [et al.] // Europ. J. of radiology. – 2012. – Vol. 81, N 10. – P. 2507–2512.
162.Kim, S. H. Hepatocellular carcinoma composed of two different histologic
types: imaging features on gadoxetic acid-enhanced liver MRI |
/ S. H. Kim, |
W. K. Jeong, Y. Kim [et al.] // Clinical a. molecular hepatology. – 2013. |
– Vol. 19, N 1. |
–P. 92–96.
163.Kim, S. H. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging / S. H. Kim, C. H. Lee, B. H. Kim [et al.] // J. of computer assistent tomography. – 2012. – Vol. 36, N 6. – P. 704–709.
164.Kim, S. Y. Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWItechniques and calculation methods / S. Y. Kim, S. S. Lee, B. Park [et al.] // J. of magnetic resonance imaging. –
2012. – Vol. 36, N 5. – P. 1131–1138.
165. Kim, Y. H. Distinguishing hepatic metastases from hemangiomas: qualitative and quantitative diagnostic performance through dual echo respiratorytriggered fast spin echo magnetic resonance imaging / Y. H. Kim, S. Saini, M. A. Blake [et al.] // J. of computere assistent tomography. – 2005. – Vol. 29, N 5. – P. 571–579.
280
166. Kim, Y. K. Feasibility of application of sensitivity encoding to the breathhold T2-weighted turbo spin-echo sequence for evaluation of focal hepatic tumors / Y. K. Kim, C. S. Kim, G. H. Chung [et al.] // Amer. J. of roentgenology: AJR. – 2005. – Vol. 184, N 2. – P. 497–504.
167. Kiryu, S. Differentiation between hemangiomas and cysts of the liver with single-shot fast-spin echo image using short and long TE / S. Kiryu, Y. Okada, K. Ohtomo // J. of computer assistent tomography. – 2002. – Vol. 26, N 5. – P. 687– 690.
168. Koh, D. M. Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging / D. M. Koh, E. Scurr,
D.J. Collins [et al.] // Europ. radiology. – 2006. – Vol. 16, N 9. – P. 1898–1905.
169.Kudo, M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology // J. of gastroenterology. – 2009. – Vol. 44, suppl. 19. – P. 112–118.
170. Kumazawa, K. Liver analysis using gadolinium-ethoxybenzyl-
diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: correlation
with histological grading and quantitative liver |
evaluation prior to hepatectomy |
/ |
K. Kumazawa, Y. Edamoto, M. Yanase [et al.] |
/ Hepatology research. – 2012. |
– |
Vol. 42, N 11. – P. 1081–1088. |
|
|
171.Landis, C. S. Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice / C. S. Landis, K. Yamanouchi, H. Zhou [et al.] // Hepatology. – 2006. – Vol. 44, N 5. – P. 1250–1258.
172.Lavelle, M. T. Dynamic contrast-enhanced three-dimensional MR imaging of liver parenchyma: source images and angiographic reconstructions to define hepatic arterial anatomy / M. T. Lavelle, V. S. Lee, N. M. Rofsky [et al.] // Radiology. – 2001. –
Vol. 218, N 2. – P. 389–394.
173. Le Bihan, D. Imagerie de diffusion in-vivo par résonance magnétique nucléaire / D. Le Bihan, E. Breton // Comptes rendus de l’Acad. des sciences. – 1985. – Vol. 301. – P. 1109–1112. – (Série 2 ; N 15).
174. Lee, J. M. Consensus report of the 4th International forum for gadolinium- ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging /